Global Ibuprofen and Codeine Phosphate Tablets Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ibuprofen and Codeine Phosphate Tablets Market Research Report 2024
Profencodeine Tablets are compound preparations composed of ibuprofen and codeine phosphate. Ibuprofen is a non-steroidal anti-inflammatory drug, which has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action may be related to the inhibition of prostaglandin synthesis; It has analgesic effect, its analgesic effect is weaker than that of morphine, and it has antitussive effect. The combined use of the two can enhance the analgesic effect.
According to Mr Accuracy reports’s new survey, global Ibuprofen and Codeine Phosphate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ibuprofen and Codeine Phosphate Tablets market research.
Key manufacturers engaged in the Ibuprofen and Codeine Phosphate Tablets industry include Reckitt Benckiser, GlaxoSmithKline, Consumer Healthcare, Crookes Healthcare, SmithKline Beecham, Boots, FARMASIERRA, ABBOTT and CANTABRIA PHARMA, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ibuprofen and Codeine Phosphate Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ibuprofen and Codeine Phosphate Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ibuprofen and Codeine Phosphate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Reckitt Benckiser
GlaxoSmithKline
Consumer Healthcare
Crookes Healthcare
SmithKline Beecham
Boots
FARMASIERRA
ABBOTT
CANTABRIA PHARMA
FARMALIDER
Mundipharma
SSL
SINOPHARM
Segment Ibuprofen (g) /Codeine Phosphate (mg)
0.2/12.5
0.2/12.8
0.2/30
0.4/30
Others
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ibuprofen and Codeine Phosphate Tablets report covers below items
Chapter 1Product Basic Information (Definition, profen (g) /Codeine Phosphate (mg) and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product profen (g) /Codeine Phosphate (mg) Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Ibuprofen and Codeine Phosphate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ibuprofen and Codeine Phosphate Tablets market research.
Key manufacturers engaged in the Ibuprofen and Codeine Phosphate Tablets industry include Reckitt Benckiser, GlaxoSmithKline, Consumer Healthcare, Crookes Healthcare, SmithKline Beecham, Boots, FARMASIERRA, ABBOTT and CANTABRIA PHARMA, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ibuprofen and Codeine Phosphate Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ibuprofen and Codeine Phosphate Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ibuprofen and Codeine Phosphate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Reckitt Benckiser
GlaxoSmithKline
Consumer Healthcare
Crookes Healthcare
SmithKline Beecham
Boots
FARMASIERRA
ABBOTT
CANTABRIA PHARMA
FARMALIDER
Mundipharma
SSL
SINOPHARM
Segment Ibuprofen (g) /Codeine Phosphate (mg)
0.2/12.5
0.2/12.8
0.2/30
0.4/30
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ibuprofen and Codeine Phosphate Tablets report covers below items
Chapter 1Product Basic Information (Definition, profen (g) /Codeine Phosphate (mg) and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product profen (g) /Codeine Phosphate (mg) Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
